$MLSS
MILESTONE SCIENTIFIC INC.

2014 Q3 Form 10-Q Financial Statement

#000156459014002113 Filed on May 13, 2014

View on sec.gov

Income Statement

Concept 2014 Q3 2014 Q1 2013 Q4
Revenue $2.535M $2.621M $2.800M
YoY Change 3.72% 5.27% 23.35%
Cost Of Revenue $830.0K $883.0K $960.0K
YoY Change 22.46% 9.01% 5.49%
Gross Profit $1.706M $1.738M $1.830M
YoY Change -3.44% 3.6% 34.56%
Gross Profit Margin 67.28% 66.31% 65.36%
Selling, General & Admin $1.838M $1.393M $1.490M
YoY Change 39.54% 0.36% -6.88%
% of Gross Profit 107.79% 80.15% 81.42%
Research & Development $29.37K $15.72K $10.00K
YoY Change 131.3% -87.1% -75.0%
% of Gross Profit 1.72% 0.9% 0.55%
Depreciation & Amortization $20.00K $4.041K $30.00K
YoY Change 0.0% -8.16% 0.0%
% of Gross Profit 1.17% 0.23% 1.64%
Operating Expenses $1.868M $1.409M $1.510M
YoY Change 40.42% -6.7% -8.48%
Operating Profit -$162.2K $329.2K $320.0K
YoY Change -137.18% 96.26% -210.34%
Interest Expense $755.00 $475.00 $690.0K
YoY Change -86.4% -98.63% -962.5%
% of Operating Profit 0.14% 215.63%
Other Income/Expense, Net $0.00 -$134.4K $0.00
YoY Change -100.0% -889.97%
Pretax Income -$358.5K $194.8K $1.020M
YoY Change -262.95% 29.89% -375.68%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0% 0.0%
Net Earnings -$358.5K $194.8K $1.020M
YoY Change -264.05% 29.25% -375.68%
Net Earnings / Revenue -14.14% 7.43% 36.43%
Basic Earnings Per Share -$0.02 $0.01
Diluted Earnings Per Share -$0.02 $0.01 $58.72K
COMMON SHARES
Basic Shares Outstanding 21.19M 17.79M
Diluted Shares Outstanding 21.19M 18.27M

Balance Sheet

Concept 2014 Q3 2014 Q1 2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.28M $1.400M $1.150M
YoY Change 2470.0% 1066.67% 576.47%
Cash & Equivalents $10.28M $1.399M $1.147M
Short-Term Investments $9.500M
Other Short-Term Assets $370.0K $240.0K $150.0K
YoY Change 208.33% 41.18% -37.5%
Inventory $3.330M $3.510M $1.322M
Prepaid Expenses
Receivables $1.620M $1.220M $1.533M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $15.61M $6.370M $4.880M
YoY Change 333.61% 139.47% 95.28%
LONG-TERM ASSETS
Property, Plant & Equipment $77.99K $20.00K $23.99K
YoY Change 159.98% -33.33% -34.5%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $820.0K $890.0K $42.08K
YoY Change 1540.0% 1680.0%
Other Assets $12.92K $10.00K $12.92K
YoY Change 29.17% 0.0% 76.53%
Total Long-Term Assets $1.660M $1.720M $3.176M
YoY Change -39.64% -45.74% 0.42%
TOTAL ASSETS
Total Short-Term Assets $15.61M $6.370M $4.880M
Total Long-Term Assets $1.660M $1.720M $3.176M
Total Assets $17.27M $8.090M $8.055M
YoY Change 171.97% 38.77% 42.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.341M $1.220M $2.020M
YoY Change -25.92% -39.9% -13.53%
Accrued Expenses $610.0K $480.0K $520.0K
YoY Change 26.32% 44.44%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.001M $2.210M $2.536M
YoY Change -21.54% -25.34% -22.57%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.001M $2.210M $2.536M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $2.000M $2.210M $2.540M
YoY Change -21.68% -35.19% -31.8%
SHAREHOLDERS EQUITY
Retained Earnings -$60.60M -$60.07M
YoY Change -1.12%
Common Stock $66.86M $66.70M
YoY Change 3.28%
Preferred Stock
YoY Change
Treasury Stock (at cost) $911.5K $911.5K
YoY Change 0.0%
Treasury Stock Shares $33.33K $33.33K
Shareholders Equity $15.27M $5.882M $5.520M
YoY Change
Total Liabilities & Shareholders Equity $17.27M $8.091M $8.055M
YoY Change 172.07% 38.78% 42.29%

Cashflow Statement

Concept 2014 Q3 2014 Q1 2013 Q4
OPERATING ACTIVITIES
Net Income -$358.5K $194.8K $1.020M
YoY Change -264.05% 29.25% -375.68%
Depreciation, Depletion And Amortization $20.00K $4.041K $30.00K
YoY Change 0.0% -8.16% 0.0%
Cash From Operating Activities -$170.0K $277.0K $820.0K
YoY Change -139.53% -431.04% -920.0%
INVESTING ACTIVITIES
Capital Expenditures -$50.00K $4.616K -$10.00K
YoY Change 439.25%
Acquisitions
YoY Change
Other Investing Activities $9.280M -$60.00K -$220.0K
YoY Change -4519.05% 20.0%
Cash From Investing Activities $9.240M -$63.32K -$230.0K
YoY Change -4500.0% 5.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 100.0K 38.00K 160.0K
YoY Change 900.0% -62.0%
NET CHANGE
Cash From Operating Activities -170.0K 277.0K 820.0K
Cash From Investing Activities 9.240M -63.32K -230.0K
Cash From Financing Activities 100.0K 38.00K 160.0K
Net Change In Cash 9.170M 251.6K 750.0K
YoY Change 3886.96% -676.58% -850.0%
FREE CASH FLOW
Cash From Operating Activities -$170.0K $277.0K $820.0K
Capital Expenditures -$50.00K $4.616K -$10.00K
Free Cash Flow -$120.0K $272.4K $830.0K
YoY Change -127.91% -422.22% -930.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-60598551
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
66677200
CY2014Q1 mlss Advances To Contract Manufacturer Non Current
AdvancesToContractManufacturerNonCurrent
218875
CY2014Q1 us-gaap Cost Method Investments
CostMethodInvestments
852295
CY2014Q1 us-gaap Customer Advances Current
CustomerAdvancesCurrent
507345
CY2014Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2014Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8090623
CY2013Q4 mlss Advances To Contract Manufacturer Non Current
AdvancesToContractManufacturerNonCurrent
1580874
CY2013Q4 us-gaap Cost Method Investments
CostMethodInvestments
924115
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
19745
CY2014Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
66844506
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-60070604
CY2014Q1 us-gaap Treasury Stock Value
TreasuryStockValue
911516
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
5882131
CY2014Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5000
CY2014Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
458614
CY2014Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
518095
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
19599
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q1 us-gaap Sales Revenue Net
SalesRevenueNet
2620834
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17787352
CY2013Q1 us-gaap Sales Revenue Net
SalesRevenueNet
2489542
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16351894
CY2014Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18268814
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16752580
CY2014Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
39877
CY2013Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-80201
CY2014Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
38000
CY2014Q1 mlss Stock Issued During Period Value Directors Compensation
StockIssuedDuringPeriodValueDirectorsCompensation
55200
CY2014Q1 mlss Stock Issued During Period Value Non Employee Services
StockIssuedDuringPeriodValueNonEmployeeServices
22500
CY2014Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
11875
CY2014Q1 us-gaap Depreciation
Depreciation
4041
CY2013Q1 us-gaap Depreciation
Depreciation
4400
CY2014Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
19593
CY2013Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
19375
CY2014Q1 mlss Common Stock And Options Issued For Compensation Consulting And Vendor Services
CommonStockAndOptionsIssuedForCompensationConsultingAndVendorServices
88052
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
1509738
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
329248
CY2014Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
882997
CY2014Q1 us-gaap Gross Profit
GrossProfit
1737837
CY2013Q1 us-gaap Gross Profit
GrossProfit
1677499
CY2014Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1392869
CY2013Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1387901
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15720
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
121837
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
1408589
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
167761
CY2013Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
17543
CY2014Q1 us-gaap Interest Expense
InterestExpense
475
CY2013Q1 us-gaap Interest Expense
InterestExpense
34558
CY2014Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-130523
CY2014Q1 mlss Income Loss From Education Joint Venture
IncomeLossFromEducationJointVenture
-3416
CY2014Q1 us-gaap Other Expenses
OtherExpenses
134414
CY2013Q1 us-gaap Other Expenses
OtherExpenses
17015
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
194834
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
150746
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2013Q1 mlss Common Stock And Options Issued For Compensation Consulting And Vendor Services
CommonStockAndOptionsIssuedForCompensationConsultingAndVendorServices
280610
CY2013Q1 us-gaap Interest Expense Other Long Term Debt
InterestExpenseOtherLongTermDebt
24419
CY2013Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-55987
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-311481
CY2013Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
246594
CY2014Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
423294
CY2013Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-13012
CY2014Q1 mlss Decrease To Advances To Contract Manufacturer
DecreaseToAdvancesToContractManufacturer
-326197
CY2013Q1 mlss Decrease To Advances To Contract Manufacturer
DecreaseToAdvancesToContractManufacturer
-39756
CY2014Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
50866
CY2013Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-73119
CY2014Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-803233
CY2013Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-306322
CY2014Q1 us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
507345
CY2014Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-31121
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
276968
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-83667
CY2014Q1 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
58703
CY2013Q1 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
50000
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4616
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
856
CY2013Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
9122
CY2014Q1 mlss Stock Issued Employees Compensation
StockIssuedEmployeesCompensation
11875
CY2013Q1 mlss Stock Issued Employees Compensation
StockIssuedEmployeesCompensation
11875
CY2014Q1 mlss Shares To Be Issued To Directors For Prepaid Directors Fees
SharesToBeIssuedToDirectorsForPrepaidDirectorsFees
55200
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-63319
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-59978
CY2014Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
38000
CY2013Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
50000
CY2013Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
50000
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
38000
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
100000
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
251649
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-43645
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
165249
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
121604
CY2014Q1 mlss Advances On Inventory Purchases Current And Non Current
AdvancesOnInventoryPurchasesCurrentAndNonCurrent
1982155
CY2014Q1 mlss Working Capital
WorkingCapital
4162674
CY2014Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
1818540
CY2014Q1 mlss Sales Credit Period
SalesCreditPeriod
P90D
CY2014Q1 mlss Number Of Development Of Products For Medical Joint Venture
NumberOfDevelopmentOfProductsForMedicalJointVenture
2
CY2013 us-gaap Legal Fees
LegalFees
39153
CY2013Q1 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
50000
CY2014Q1 mlss Advance Payment To Supplier
AdvancePaymentToSupplier
1982000
CY2013Q4 mlss Advance Payment To Supplier
AdvancePaymentToSupplier
2308000
CY2013Q4 mlss Advances On Inventory Purchases Current And Non Current
AdvancesOnInventoryPurchasesCurrentAndNonCurrent
2308352
CY2014Q1 mlss Utilization Period Of Advance
UtilizationPeriodOfAdvance
P12M
CY2008Q4 us-gaap Related Party Transaction Due From To Related Party
RelatedPartyTransactionDueFromToRelatedParty
450000
CY2014Q1 us-gaap Related Party Transaction Date
RelatedPartyTransactionDate
2015-01-05
CY2014Q1 us-gaap Line Of Credit Facility Interest Rate During Period
LineOfCreditFacilityInterestRateDuringPeriod
0.12
CY2013Q3 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
614344
CY2013Q1 mlss Line Of Credit Facility Accrued Interest
LineOfCreditFacilityAccruedInterest
306313
CY2013Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
1300000
CY2014Q1 mlss Effective Income Tax Rate Reconciliation At Federal Statutory Rate And State And Local Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryRateAndStateAndLocalIncomeTaxRate
0.40
CY2013 mlss Effective Income Tax Rate Reconciliation At Federal Statutory Rate And State And Local Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryRateAndStateAndLocalIncomeTaxRate
0.40
CY2014Q1 mlss Net Income Loss At Federal Statutory Income Tax Rate
NetIncomeLossAtFederalStatutoryIncomeTaxRate
151000
CY2013 mlss Net Income Loss At Federal Statutory Income Tax Rate
NetIncomeLossAtFederalStatutoryIncomeTaxRate
42000
CY2014Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
6986
CY2014Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
95000
CY2014Q1 us-gaap Share Price
SharePrice
0.40
CY2014Q1 mlss Stock Issued During Period Shares Non Employee Services
StockIssuedDuringPeriodSharesNonEmployeeServices
13939
CY2014Q1 mlss Stock Issued During Period Shares Directors Compensation
StockIssuedDuringPeriodSharesDirectorsCompensation
30000
CY2014Q1 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
824574
CY2013Q1 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
663420
CY2014Q1 us-gaap Accounts Payable Related Parties Current And Noncurrent
AccountsPayableRelatedPartiesCurrentAndNoncurrent
671777
CY2013Q4 us-gaap Accounts Payable Related Parties Current And Noncurrent
AccountsPayableRelatedPartiesCurrentAndNoncurrent
1024653
CY2014Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
50000
CY2014Q1 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.50
CY2014Q1 mlss Accounts Receivable Net Current And Noncurrent Percentage
AccountsReceivableNetCurrentAndNoncurrentPercentage
0.51
CY2013Q4 mlss Accounts Receivable Net Current And Noncurrent Percentage
AccountsReceivableNetCurrentAndNoncurrentPercentage
0.48
CY2014Q1 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
0.57
CY2013Q1 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
0.49
CY2014Q1 mlss Accounts Receivable Net Current And Noncurrent
AccountsReceivableNetCurrentAndNoncurrent
621062
CY2013Q4 mlss Accounts Receivable Net Current And Noncurrent
AccountsReceivableNetCurrentAndNoncurrent
732762
CY2013Q1 mlss Number Of Customers
NumberOfCustomers
3
CY2014Q1 mlss Number Of Major Customers
NumberOfMajorCustomers
1
CY2013 mlss Number Of Major Customers
NumberOfMajorCustomers
1
CY2014Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2620834
CY2013Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2489542
CY2014Q1 us-gaap Payments For Postemployment Benefits
PaymentsForPostemploymentBenefits
203111
CY2014Q1 mlss Define Benefit Plan Payment Period
DefineBenefitPlanPaymentPeriod
P5Y
CY2014Q1 us-gaap Pension Expense
PensionExpense
17000
CY2014Q1 mlss Additional Payment To Director As Percentage Of Sales Value Using Certain Specify Technology
AdditionalPaymentToDirectorAsPercentageOfSalesValueUsingCertainSpecifyTechnology
0.025
CY2014Q1 mlss Additional Payment To Director As Percentage Of Sales Value Using Other Kind Of Technology
AdditionalPaymentToDirectorAsPercentageOfSalesValueUsingOtherKindOfTechnology
0.05
CY2014Q1 mlss Consulting Fees To Director
ConsultingFeesToDirector
14300
CY2012Q1 mlss Consulting Fees To Director
ConsultingFeesToDirector
39000
CY2013Q3 mlss Shareholder Agreement Period
ShareholderAgreementPeriod
P3Y
CY2013Q3 us-gaap Servicing Fees
ServicingFees
100000
CY2010Q1 us-gaap Long Term Purchase Commitment Minimum Quantity Required
LongTermPurchaseCommitmentMinimumQuantityRequired
12000
CY2010Q1 us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
5261640

Files In Submission

Name View Source Status
0001564590-14-002113-index-headers.html Edgar Link pending
0001564590-14-002113-index.html Edgar Link pending
0001564590-14-002113.txt Edgar Link pending
0001564590-14-002113-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
mlss-10q_20140331.htm Edgar Link pending
mlss-20140331.xml Edgar Link completed
mlss-20140331.xsd Edgar Link pending
mlss-20140331_cal.xml Edgar Link unprocessable
mlss-20140331_def.xml Edgar Link unprocessable
mlss-20140331_lab.xml Edgar Link unprocessable
mlss-20140331_pre.xml Edgar Link unprocessable
mlss-ex10_20140331373.htm Edgar Link pending
mlss-ex31_201403317.htm Edgar Link pending
mlss-ex31_201403318.htm Edgar Link pending
mlss-ex32_2014033110.htm Edgar Link pending
mlss-ex32_201403319.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending